Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M394Revenue $M7.0Net Margin (%)-604.9Z-Score-9.8
Enterprise Value $M352EPS $-0.7Operating Margin %-616.9F-Score5
P/E(ttm))0Cash Flow Per Share $-1.0Pre-tax Margin (%)-604.9Higher ROA y-yN
Price/Book14.910-y EBITDA Growth Rate %-28.1Quick Ratio4.6Cash flow > EarningsY
Price/Sales47.75-y EBITDA Growth Rate %-16.1Current Ratio4.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-52.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-112.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M70.8ROI % (ttm)-60.6Gross Margin Increase y-yY

Gurus Latest Trades with AGEN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AGENGeorge Soros 2014-06-30 Sold Out $2.41 - $3.61
($2.94)
$ 5.5747%Sold Out0
AGENJean-Marie Eveillard 2014-06-30 Sold Out $2.41 - $3.61
($2.94)
$ 5.5747%Sold Out0
AGENGeorge Soros 2014-03-31 Buy $2.64 - $5.1
($3.52)
$ 5.5737%New holding102,200
AGENJean-Marie Eveillard 2014-03-31 Buy $2.64 - $5.1
($3.52)
$ 5.5737%New holding200,000
AGENRobert Bruce 2012-06-30 Buy 0.52%$4.84 - $6.9
($5.78)
$ 5.57-4%New holding233,515
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AGEN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
QVT Associates GP LLC10% Owner 2015-01-09Sell2,343,630$5.314.33 view
Wentworth KerryVP, Clinical, Reg & Qual 2014-02-26Sell5,000$510.8 view
Malik ShahzadDirector 2014-02-12Sell0$010.8 view
QVT Associates GP LLC10% Owner 2014-02-05Sell0$010.8 view
Valentine KarenVP General Counsel 2014-01-23Sell2,850$3.558.29 view
Baysal OzerChief Business Officer 2013-06-13Sell0$058.29 view
Sharp ShaliniDirector 2013-01-30Sell288$4.3627.06 view
Sharp ShaliniDirector 2012-10-31Sell288$4.425.91 view
Sharp ShaliniDirector 2012-08-29Sell288$4.6419.4 view
Valentine KarenVP and General Counsel 2008-06-04Sell0$019.4 view

Press Releases about AGEN :

    Quarterly/Annual Reports about AGEN:

    News about AGEN:

    Articles On GuruFocus.com
    rusty Jan 26 2015 
    Agenus Inc.: Ingeniously Designed Vaccines To Galvanized Tomorrow's Medicine Jul 25 2014 
    Agenus: Grossly Undervalued GlaxoSmithKline Acquisition Target Sep 11 2012 
    5 Speculative Biotech Stocks to Consider Buying Now Jan 24 2012 
    Weekly CEO Buys Highlight: CTAS, VRX, TAT, AGEN, MRK Aug 20 2011 
    Chairman & CEO of Agenus Inc. (AGEN) Garo Armen Buys 2,150,976 Shares Aug 18 2011 
    Antigenics Inc. Reports Operating Results (10-K) Mar 16 2011 
    Antigenics Inc. Reports Operating Results (10-Q) Nov 09 2010 
    Antigenics Inc. (AGEN) CFO Shalini Sharp sells 1,500 Shares Oct 28 2010 
    Antigenics Inc. (AGEN) CFO Shalini Sharp sells 2,000 Shares Sep 14 2010 

    More From Other Websites
    AGENUS INC Files SEC form 8-K, Entry into a Material Definitive Agreement Apr 08 2015
    Agenus Acquires Celexion Assets and Expands Its Antibody Discovery Platform Apr 08 2015
    Lightning Round: Be careful-this lurks everywhere Apr 01 2015
    Agenus draws vote of confidence Mar 30 2015
    Agenus Boosted by Big Pharma Deals Mar 24 2015
    AGENUS INC Financials Mar 21 2015
    AGENUS INC Files SEC form 10-K, Annual Report Mar 16 2015
    Agenus reports 4Q loss Feb 26 2015
    Agenus reports 4Q loss Feb 26 2015
    Agenus (AGEN) Reports Wider-than-Expected Q4 Loss - Tale of the Tape Feb 26 2015
    Q3 2014 Agenus Inc Earnings Release - Before Market Open Feb 26 2015
    AGENUS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an... Feb 26 2015
    Agenus Reports Fourth Quarter and Full Year 2014 Financial Results Feb 26 2015
    Agenus to Present at the Cowen and Company 35th Annual Health Care Conference Feb 25 2015
    Agenus to Report Fourth Quarter and Year End 2014 Financial Results on February 26, 2015; Conference... Feb 20 2015
    AGENUS INC Files SEC form 8-K, Other Events Feb 19 2015
    Agenus to Present at the 17th Annual BIO CEO & Investor Conference Feb 03 2015
    Biotech Stock Mailbag: Arena Pharma, Agenus, EnteroMedics Jan 23 2015
    Agenus (AGEN) Shares March Higher, Can It Continue? - Tale of the Tape Jan 16 2015
    The Zacks Analyst Blog Highlights: NPS Pharmaceuticals, Celgene, Pharmacyclics, Agenus and Incyte -... Jan 15 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK